Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nucleic Acid Medicines. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116444589B reveals high-yield liquid phase synthesis for GalNAc conjugates. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates significantly.